acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI
- 2049223
- RxNorm name
- acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- Display name
- Acetaminophen/guaiFENesin/Phenylephrine (Oral Pill)
- Full name
- acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- Term type
- SCD
- Status
- Active
- Strength
- 325-200-5 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-11-08 10:05:25
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082018
- Active start
- 082018
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 325 MG / 1 EACH | acetaminophen | acetaminophen |
| guaifenesin | 200 MG / 1 EACH | guaifenesin | guaifenesin |
| phenylephrine hydrochloride | 5 MG / 1 EACH | phenylephrine | phenylephrine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
| guaifenesin | 5032 |
| phenylephrine | 8163 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule | 1 | NAMES |
| RxNorm Synonym | APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 2049223 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 37000-951-24 | 37000-951 | Vicks Sinex Severe Acetaminophen, Phenylephrine HCl, Guaifenesin | The Procter & Gamble Manufacturing Company | M012 |
| 82706-020-01 | 82706-020 | AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine Hydrocloride | VIVUNT PHARMA LLC | M012 |
| 82706-020-03 | 82706-020 | AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine Hydrocloride | VIVUNT PHARMA LLC | M012 |
| 82706-020-04 | 82706-020 | AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine Hydrocloride | VIVUNT PHARMA LLC | M012 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | 37000-951-24 37000-951 37000095124 2049223 |
| AXIV Sinus Severe Mucus | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCLORIDE | VIVUNT PHARMA LLC | 13245298-8b78-e177-e063-6294a90a6bec | 2025-09-17 | Warnings | 82706-020-01 82706-020-04 82706-020-03 82706-020 82706002001 82706002003 82706002002 82706002004 2049223 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9a106291-edda-2135-e053-2995a90a44fd | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule [PSN] · acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule [SCD] · APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule [SY] | 3 | 11 | VICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCaps | 20251112 |
| 13245298-8b78-e177-e063-6294a90a6bec | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule [PSN] · acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule [SCD] · APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule [SY] | 3 | 6 | AXIV - Sinus Severe + Mucus | 20250917 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 9a106291-edda-2135-e053-2995a90a44fd | VICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCaps | The Procter & Gamble Manufacturing Company | 20261002 |
| 9a106291-edda-2135-e053-2995a90a44fd | VICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCaps | The Procter & Gamble Manufacturing Company | 20251112 |
| 13245298-8b78-e177-e063-6294a90a6bec | AXIV - Sinus Severe + Mucus | VIVUNT PHARMA LLC | 20250917 |
| 9a106291-edda-2135-e053-2995a90a44fd | VICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCaps | The Procter & Gamble Manufacturing Company | 20250806 |
| de9eb2d5-ba54-4637-e053-2995a90a0451 | AXIM - Sinus Severe + Mucus | VIVUNT PHARMA LLC | 20240614 |
| 6f1662e7-5e3b-938d-e053-2991aa0abca4 | VICKS ® Sinex ™ Severe Congestion LiquiCaps LiquiCaps | The Procter & Gamble Manufacturing Company | 20191219 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | phenylephrine | |
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ATC1-4 | phenylephrine | |
| ATC | R01BA | Sympathomimetics | ATC1-4 | phenylephrine | |
| ATC | S01FB | Sympathomimetics excl. antiglaucoma preparations | ATC1-4 | phenylephrine | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | phenylephrine | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | phenylephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | phenylephrine | |
| FDASPL | N0000186105 | alpha-1 Adrenergic Agonist | EPC | has_epc | phenylephrine |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine hydrochloride |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine hydrochloride |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine hydrochloride |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 325 MG / 200 MG / 5 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule |
| NAMES | Tallman Synonym | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule |
| NAMES | Tallman Synonym | APAP 325 MG / guaiFENesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |